CD30 ligand Molekülinformation
Molecule Name
Tumor necrosis factor ligand superfamily member 8
Molekülalias
CD30-L,CD153,TNFSF8,CD30L,CD30LG,CD153 antigen,CD30 antigen ligand,CD30 Ligand
Drug Development Progress
Anzahl der klinischen Arzneimittel0
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePreclinical
Target-Alias
CD153，CD30LG，CD30 ligand，CD30-L，CD30L，Tumor Necrosis Factor (Ligand) Superfamily， Member 8，TNF Superfamily Member 8，Tumor Necrosis Factor Ligand Superfamily Member 8，TNLG3A，CD153 Antigen，Tumor Necrosis Factor Superfamily Member 8，Tumor Necrosis Factor Ligand 3A，CD30 Antigen Ligand
Molekülhintergrund
CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor
(TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.
CD30 ligand Produktliste
You Have Viewed 0 Of 0 Results